SCHEMBL14155126

SCHEMBL14155126

CC(C)(CC(C)(C)n1ncc2ccc(F)cc21)NO

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 4/20 0.43
▸ CYP11B2 P19099 4/20 0.43
▸ HTR2A P28223 2/20 0.42
▸ HTR2C P28335 2/20 0.42
▸ ADRA2A P08913 1/20 0.36
▸ ADRA2B P18089 1/20 0.36
▸ ADRA2C P18825 1/20 0.36
▸ SMO Q99835 2/20 0.36
▸ NR3C1 P04150 1/20 0.34
▸ HTR1A P08908 1/20 0.32
▸ HTR1B P28222 1/20 0.32
▸ HTR1F P30939 1/20 0.32
▸ SCD O00767 2/20 0.32
▸ MAPK14 Q16539 1/20 0.32
▸ PDE1C Q14123 1/20 0.31
▸ MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14155125 0.84 KMO (0.46) CYP11B1CYP11B2MAPK1
SCHEMBL14155122 0.81 CYP11B1 (0.37) CYP11B1CYP11B2
SCHEMBL25859519 0.68 HTR2C (0.57) CYP11B1CYP11B2HTR2AHTR2CADRA2A
SCHEMBL30544978 0.68 HTR2A (0.57) CYP11B1CYP11B2HTR2AHTR2CADRA2A
SCHEMBL22357749 0.66 HTR2A (0.36) HTR2AHTR2CADRA2AADRA2BADRA2C
SCHEMBL30816458 0.65 HTR2A (0.57) CYP11B1CYP11B2HTR2AHTR2CADRA2A
SCHEMBL27165368 0.65 HTR2A (0.57) CYP11B1CYP11B2HTR2AHTR2CADRA2A
SCHEMBL2594426 0.65 HTR2A (0.53) HTR2AHTR2CSCD
SCHEMBL29520619 0.64 HTR2A (0.65) CYP11B1CYP11B2HTR2AHTR2CADRA2A
Hydrochloric Acid SCHEMBL8854161 0.64 CYP11B1 (0.41) CYP11B1CYP11B2HTR2AHTR2CADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1827427-B1 ARYLOXYETHYLAMINE DERIVATIVES WITH A COMBINATION OF PARTIAL DOPAMINE-D2 RECEPTOR AGONISM AND SEROTONIN REUPTAKE INHIBITION SOLVAY PHARM BV (NL) 2008-07-23 — — EP disclosed
Send feedback